Werewolf Therapeutics earnings were -$70.5M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest HOWL earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$20.4M, up 22.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, HOWL reported annual earnings of -$70.5M, with 88.7% growth.
Werewolf Therapeutics Earnings Reports & History FAQ
What were Werewolf Therapeutics's earnings last quarter?
Werewolf Therapeutics (NASDAQ: HOWL) reported Q4 2024 earnings per share (EPS) of -$0.46, up 39.39% year over year. Total HOWL earnings for the quarter were -$20.40 million. In the same quarter last year, Werewolf Therapeutics's earnings per share (EPS) was -$0.33.
Is Werewolf Therapeutics profitable or losing money?
As of the last Werewolf Therapeutics earnings report, Werewolf Therapeutics is currently losing money. Werewolf Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$70.52 million, a 88.7% increase year over year.
What was HOWL's earnings growth in the past year?
As of Werewolf Therapeutics's earnings date in Q2 2025, Werewolf Therapeutics's earnings has grown year over year. HOWL earnings in the past year totalled -$70.52 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.